首页> 外文期刊>Injury >Investigating a new drug delivery nano composite membrane system based on PVA/PCL and PVA/HA(PEG) for the controlled release of biopharmaceuticals for bone infections
【24h】

Investigating a new drug delivery nano composite membrane system based on PVA/PCL and PVA/HA(PEG) for the controlled release of biopharmaceuticals for bone infections

机译:研究基于PVA / PCL和PVA / HA(PEG)的新型药物输送纳米复合膜系统,以控制释放用于骨感染的生物药物

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The capability for sustained and gradual release of pharmaceuticals is a major requirement in the development of a guided antimicrobial bacterial control system for clinical applications. In this study, PVA gels with varying constituents that were manufactured via a refreeze/thawing route, were found to have excellent potential for antimicrobial delivery for bone infections. Cefuroxime Sodium with poly(ethylene glycol) was incorporated into 2 delivery systems poly(e-caprolactone) (PCL) and hydroxyapatite (HA), by a modified emulsion process. Our results indicate that the Cefuroxime Sodium released from poly(e-caprolactone) in PVA was tailored to a sustained release over more than 45 days, while the release from hydroxyapatite PVA reach burst maximum after 20 days. These PVA hydrogel-systems were also capable of controlled and sustained release of other biopharmaceuticals. (C) 2015 Elsevier Ltd. All rights reserved.
机译:药物的持续和逐步释放的能力是开发用于临床应用的引导型抗菌细菌控制系统的主要要求。在这项研究中,发现通过重冻/解冻途径生产的具有不同成分的PVA凝胶具有极强的抗菌潜力,可用于骨感染。通过改良的乳化工艺,将头孢呋辛钠与聚(乙二醇)钠混入2种递送系统聚(ε-己内酯)(PCL)和羟基磷灰石(HA)中。我们的结果表明,从聚乙烯醇中的聚(ε-己内酯)中释放出的头孢呋辛钠经过专门设计,可以在超过45天的时间内持续释放,而从羟基磷灰石PVA中释放的释放量在20天后达到最大值。这些PVA水凝胶系统还能够控制和持续释放其他生物制药。 (C)2015 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号